Peripherally administered TNF inhibitor is not protective against α-synuclein-induced dopaminergic neuronal death in rats
The underlying cause of neuronal loss in Parkinson's disease (PD) remains unknown, but evidence implicates neuroinflammation in PD pathobiology. The pro-inflammatory cytokine soluble tumor necrosis factor (TNF) seems to play an important role and thus has been proposed as a therapeutic target f...
Saved in:
| Main Authors: | Josefine R. Christiansen, Sara A. Ferreira, David E. Szymkowski, Johan Jakobsson, Malú Gámez Tansey, Marina Romero-Ramos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996125000191 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
by: Filip Fredlund, et al.
Published: (2025-04-01) -
Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms
by: Lucia Lage, et al.
Published: (2025-03-01) -
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway
by: Yalan Cheng, et al.
Published: (2023-06-01) -
Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01) -
Characterization of factors that influence rAAV yield and quality when produced using rHSV co-infection
by: Xiaofei E, et al.
Published: (2025-06-01)